Date prepared: July 22, 2023<\/p>\n\n\n\n
Abbreviated name of the issuer: <\/p>\n\n\n\n
CELON PHARMA S.A.<\/p>\n\n\n\n
Subject: Resolutions adopted by the Ordinary General Meeting of Celon Pharma S.A. on June 22, 2023.<\/p>\n\n\n\n
Legal basis <\/p>\n\n\n\n
Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodic information<\/p>\n\n\n\n
Content of the report:<\/p>\n\n\n\n
The Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby publishes the text of the resolutions adopted by the Ordinary General Meeting of the Company on June 22, 2023 and the “Report of the Supervisory Board of Celon Pharma S.A. for the financial year 2022” approved by Resolution No. 7 and the “Report on remuneration of Members of the Management Board and the Supervisory Board of Celon Pharma S.A. for the period 01.01.2021.- 31.12.2021”, for which an opinion in the form of Resolution No. 16 was issued.<\/p>\n\n\n\n
During the Ordinary General Meeting, no item on the agenda has been withdrawn and no objection to any of the adopted resolutions has been raised. Since the electronic vote-counting system was used, no resolution on the election of the Returning Committee has been adopted. All resolutions subjected to the vote have been adopted.<\/p>\n","protected":false},"excerpt":{"rendered":"